ANI Pharmaceuticals, Inc. (ANIP) revenue

Revenue · fiscal 2025
$883.37M

ANI Pharmaceuticals, Inc. (ANIP) reported revenue of $883.37M in fiscal 2025 (the year ended December 31, 2025). That is 43.8% higher than the $614.38M of fiscal 2024. Figures as of 18 Nov 2026, 09:09 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$883.37M
Change on fiscal 2024
+43.8%
Growth, 5 years
+33.5% a year
Growth, 10 years
+27.7% a year
Highest on record
$883.37Mfiscal 2025
Lowest on record
$435.16Kfiscal 2011
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

ANI Pharmaceuticals, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 33.5% a year; over ten years the rate was 27.7% a year. Across the 17 fiscal years on record (2009–2025), the highest was $883.37M in fiscal 2025 and the lowest $435.16K in fiscal 2011.

History · 17 fiscal years

Revenue by fiscal year

ANI Pharmaceuticals, Inc. revenue, year by year

ANI Pharmaceuticals, Inc. (ANIP) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$883.37M 43.8% up
2024$614.38M 26.2% up
2023$486.82M 53.9% up
2022$316.39M 46.4% up
2021$216.14M 3.7% up
2020$208.48M 0.9% up
2019$206.55M 2.5% up
2018$201.58M 14.0% up
2017$176.84M 37.5% up
2016$128.62M 68.5% up
2015$76.32M 36.4% up
2014$55.97M 86.1% up
2013$30.08M 47.7% up
2012$20.37M 4,581.3% up
2011$435.16K 82.4% down
2010$2.47M 96.7% up
2009$1.26M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on ANIP

ANI Pharmaceuticals, Inc., figure by figure

ANI Pharmaceuticals, Inc. (ANIP) overview: price, valuation and scorecard

ANI Pharmaceuticals, Inc. revenue: questions and answers

What is ANI Pharmaceuticals, Inc.'s revenue?

ANI Pharmaceuticals, Inc. (ANIP) reported revenue of $883.37M in fiscal 2025 (the year ended December 31, 2025). That is 43.8% higher than the $614.38M of fiscal 2024.

What is the growth rate of ANI Pharmaceuticals, Inc.'s revenue?

Over the five fiscal years to 2025 revenue grew at a compound 33.5% a year; over ten years the rate was 27.7% a year.

What are the highest and lowest revenue figures on record for ANI Pharmaceuticals, Inc.?

Across the 17 fiscal years on record (2009–2025), the highest was $883.37M in fiscal 2025 and the lowest $435.16K in fiscal 2011.

How is ANI Pharmaceuticals, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For ANI Pharmaceuticals, Inc. it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ANI Pharmaceuticals, Inc. (ANIP) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/ANIP/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.